Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule modulators Expanded collaboration into Ono’s other priority areas of interest, including neurology and immunology, following the ongoing partnership in oncology Obtaining exclusive worldwide option rights for the discovery, development, and commercialization of small molecule modulators generated by […]


9 d.
Science
ID: -7435322123881485223


Similar News expand_more


Science
Science
Science
Science
Technology
Science
Science
Science
Science
Technology
Technology
Economics
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Science
Education
Science
Technology
Technology
Technology
Technology
Technology
Economics
Science
Technology
Science
Technology
Technology
Technology
Technology
Economics
Economics
Science
Science
Economics
Science
Science
Technology
Science
Education
Technology
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down